Cellular distribution of the rat D-4 dopamine receptor protein in the CNS using anti-receptor antisera

被引:173
作者
Ariano, MA [1 ]
Wang, J [1 ]
Noblett, KL [1 ]
Larson, ER [1 ]
Sibley, DR [1 ]
机构
[1] NINCDS, EXPT THERAPEUT BRANCH, MOL NEUROPHARMACOL SECT, BETHESDA, MD 20892 USA
关键词
dopamine; cellular expression; anti-peptide antisera; forebrain; mRNA;
D O I
10.1016/S0006-8993(96)01422-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A polyclonal antiserum was generated against a unique peptide fragment in the rat D-4 dopamine (DA) receptor. The titer was monitored using solid-phase ELISA and once it was established, specificity was assessed using Chinese Hamster Ovary (CHO) cells, stably transfected with the full-length cDNA for the rat D-4 DA receptor. Immunofluorescent staining produced by incubation with the anti-D-4 DA receptor antiserum was selective for D-4 DA receptor-transfected CHO cells, and was expressed at their cell membranes and cytoplasm. Attenuated staining for D-4 DA receptor protein was visible in untransfected, K1 CHO cells, and in D-2 or D-3 DA receptor-transfected CHO cells. The regional and cellular CNS distribution patterns for the D-4, DA receptor subtype were examined, and illustrated significant protein levels within the frontal (FCx) and parietal cortices. Lesser amounts of receptor protein staining occurred in the thalamus, globus pallidus, hippocampus, cerebellar vermis, and very low expression was detected in the striatum (CPu). D-4 DA receptor protein staining was correlated with the cellular expression of its mRNA transcripts in these same brain regions using concurrent fluorescent analyses. The homologous coincidence in staining patterns for the D-4 DA receptor transcripts and encoded proteins in identified neurons of the FCx and CPu showed variations in receptor expression in these identified basal ganglia pathways. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 47 条
[31]   INHIBITORY EFFECTS OF VENTRAL TEGMENTAL AREA STIMULATION ON THE ACTIVITY OF PREFRONTAL CORTICAL-NEURONS - EVIDENCE FOR THE INVOLVEMENT OF BOTH DOPAMINERGIC AND GABAERGIC COMPONENTS [J].
PIROT, S ;
GODBOUT, R ;
MANTZ, J ;
TASSIN, JP ;
GLOWINSKI, J ;
THIERRY, AM .
NEUROSCIENCE, 1992, 49 (04) :857-865
[32]   DEVELOPMENTS IN THE DRUG-TREATMENT OF SCHIZOPHRENIA [J].
REYNOLDS, GP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (03) :116-121
[33]   THE CASE FOR FRONTOSTRIATAL DYSFUNCTION IN SCHIZOPHRENIA [J].
ROBBINS, TW .
SCHIZOPHRENIA BULLETIN, 1990, 16 (03) :391-402
[34]   MARKED INHIBITION OF MESOLIMBIC DOPAMINE RELEASE - A COMMON FEATURE OF ETHANOL, MORPHINE, COCAINE AND AMPHETAMINE ABSTINENCE IN RATS [J].
ROSSETTI, ZL ;
HMAIDAN, Y ;
GESSA, GL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 221 (2-3) :227-234
[35]   LONG-TERM HALOPERIDOL ELEVATES DOPAMINE D-4 RECEPTORS BY 2-FOLD IN RATS [J].
SCHOOTS, O ;
SEEMAN, P ;
GUAN, HC ;
PATERSON, AD ;
VANTOL, HHM .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (01) :67-72
[36]   DOPAMINE D4 RECEPTORS ELEVATED IN SCHIZOPHRENIA [J].
SEEMAN, P ;
GUAN, HC ;
VANTOL, HHM .
NATURE, 1993, 365 (6445) :441-445
[37]  
SESACK SR, 1989, J PHARMACOL EXP THER, V248, P1323
[38]   TOPOGRAPHICAL ORGANIZATION OF THE EFFERENT PROJECTIONS OF THE MEDIAL PREFRONTAL CORTEX IN THE RAT - AN ANTEROGRADE TRACT-TRACING STUDY WITH PHASEOLUS-VULGARIS LEUCOAGGLUTININ [J].
SESACK, SR ;
DEUTCH, AY ;
ROTH, RH ;
BUNNEY, BS .
JOURNAL OF COMPARATIVE NEUROLOGY, 1989, 290 (02) :213-242
[39]  
Sibley D.R., 1995, MOL CELLULAR MECH NE, P255
[40]   MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL DOPAMINE RECEPTOR (D3) AS A TARGET FOR NEUROLEPTICS [J].
SOKOLOFF, P ;
GIROS, B ;
MARTRES, MP ;
BOUTHENET, ML ;
SCHWARTZ, JC .
NATURE, 1990, 347 (6289) :146-151